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ABSTRACT - With the purpose of analyzing the neurological involvement due to systemic lupus erythematosus 
(SLE), we evaluated 17 female patients who were seen regularly at the hospital and had been diagnosed as 
having SLE according to classification criteria proposed by the American College of Rheumatology revised in 
1982, before the age of 16. Neurological involvement was detected in 12 patients(71%): headache (35%), 
extrapyramidal syndrome (35%), epileptic syndrome (24%) pyramidal syndrome (24%), peripheral neuropathy 
(12%) and optic neuritis (6%). The findings of CT scan (58%) and cerebrospinal fluid (50%) were most closely 
correlated to clinical neurological involvement. 
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Lupus erítematoso sistêmico juvenil: comprometimento neurológico 
RESUMO - Com o objetivo de analisar o comprometimento neurológico secundário ao lupus eritematoso sistêmico 
(LES), avaliamos pacientes que estavam em acompanhamento ambulatorial. Foram selecionadas 17 pacientes 
do sexo feminino cujo diagnóstico do LES foi até a idade de 16 anos, e preencheu os critérios para a classificação 
propostos pelo Colégio Americano de Reumatologia revisados em 1982. O comprometimento neurológico foi 
observado em 12 pacientes(71%): cefaléia (35%), síndrome extrapiramidal (35%), síndrome epiléptica (24%), 
síndrome piramidal (24%), neuropatia periférica (12%) e neurite óptica (6%). Dos exames complementares a 
tomografia coputadorizada de crânio (58%) e o líquido cefalorraquidiano (50%) mostraram maior correlação 
com a presença de comprometimento neurológico. 
PALAVRAS-CHAVE: lupus eritematoso sistêmico juvenil, comprometimento neurológico. 
In the literature few publications concentrate on the clinical neurological involvement in 
juvenile systemic lupus erythematosus (SLE). Mostly these are reports on SLE in children in whom 
only some neurological manifestation is described. 
We performed this study in order to characterize neurological involvement due to the direct 
action of the juvenile SLE on central and peripheral nervous system. 
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PATIENTS AND METHODS 
Seventeen female patients whose SLE was identified before they were 16 years old and complied with 
classification criteria proposed by ACR revised in 19827, were submitted to a clinical neurological assessment 
and complementary exams: electroencephalogram (EEG); cerebrospinal fluid (CSF); cranial computerized 
tomography (CT); electroneuromyography (ENMG); brainstem auditory evoked potentials (BAEP) and 
antiphospholipidic antibody research. 
The age at which the first neurologic assessment took place ranged from 3 to 18 years (mean: 11,4). 
In order to establish whether the illness was active or not the Urowitz et al.8 criteria was used. 
Neurological symptoms and/or abnormal clinical neurological exam and/or abnormal complementary 
exams allowed us to identify neurological involvement. 
Patients with neurological injury secondary to the impairment of other organs and/or drug action were 
excluded. 
RESULTS 
Twelve patients (71%) had neurological involvement. Of these, 7 (58%) presented two or 
more different clinical neurological manifestations and 5 (42%) only one. 
The relationship in time between the SLE diagnosis and the clinical neurological manifestations 
varied: in 1 patient (8%) the manifestations preceded the diagnosis; in 2 (17%) they were concomitant; 
in 7 (58%) the manifestations appeared in the course of the SLE; in 2 (17%) they were indeterminate. 
The central nervous system proved to be more involved (100%) than the peripheral (25%). 
The SLE was active at the time of the diagnosis of the clinical neurological manifestations in 
9 patients (75%). 
The clinical neurological manifestations in juvenile SLE patients are in Table 1. 
The complementary exams in juvenile SLE patients are in Table 2. 
DISCUSSION 
SLE is an autoimmune systemic chronic disease with inflammation in connective tissue and 
blood vessels. 
The neurological involvement has not received the same attention as the other systemic 
manifestations because it is rarely the first manifestation. The pathophysiological mechanisms 
related to this involvement which can impair the peripheric or central nervous system are still 
questioned. Neither the primary vessels injury nor the infections, arterial hypertension nor reactions 
to medicine account for all the nervous system involvement. 
The first article to emphasize neurological involvement in SLE children was that of Gold and 
Yahr4 followed by that of Cassidy et al.2, Yancey et al.9, King et al.5, and Davies and Ansell 3. 
Most articles do not distinguish between neurological and psychiatric impairment labeling 
them neuropsychiatric disorders. 
The central nervous system involvement in children has been reported as varying from 13 to 
60%lAfi. However in our study we found an involvement of 71%. This discrepancy may be due to 
the fact that we also assessed patients who had been considered neurologically asymptomatic as far 
as pediatricians were concerned. 
The results of our study confirm the importance of neurological assessment of every child or 
adolescent with SLE. 
REFERENCES 
1. Bastos WA, Sacchetti SB.Lúpus eritematoso sistêmico. In Oliveira SRF.Azevedo ECL.Reumatologia pediátrica.Rio de 
Janeiro: Medsi,1991:189-210. 
2. Cassidy JT, Sullivan DB, Petty RE, Dale C- Lupus nephritis and encephalopathy: prognosis in 58 children. Arthritis 
Rheum 1977;20:315-322. 
3. Davies UM, Ansell BM. Central nervous system manifestations in juvenile systemic lupus erythematosus: a problem of 
management. J Rheumatol 1988;15:1720-1721. 
4. Gold AP, Yahr MD.Childhood lupus erythematosus: a clinical and pathologycal study of the neurological manifestations. 
Am Neurol Assoc Trans 1960,85:96-102. 
5. King J, Aukett A, Smith MF.Hosking G.Ward AM. Cerebral lupus erythematosus. Arch Dis Child 1988,63:968-970. 
6. Sacchetti SB. Lupus eritematoso sistêmico na infância: estudo clínico laboratorial e histológico de 40 casos. Tese de 
Mestrado, Universidade de São Paulo, 1991. 
7. Tan EM, Cohen AS, Fries JF, Masi AT, Macshane DJ, Rothefield NF, Shaller JG, Talai N, Winchester RJ. The 1982 revised 
criteria for the classification of systemic lupus erythematosus. Arthritis Reumatism 1982;25:1271-1277. 
8. Urowitz MB. Gladman DD.Tozman ECL, Goldsmith CH.The lupus activity criteria count(LACC).J.Rheumatol 1984;11:783-787. 
9. Yancey CL, Doughty RA, Atreya BH. Central nervous system involvement in childhood systemic lupus erythematosus. 
Arthritis Rheumatism 1981 ;24:1389-1395. 
